Corporate-sponsored education will focus on blood availability and the intercept blood system
Oct. 13, 2022
Inventory management for platelet components and of fibrinogen sources (cryoprecipitated antihemophilic factor) can be challenging given their short shelf-life.
An upcoming Science and Innovation Forum presented by Cerus Corporation will describe how pathogen-reduced platelets (Intercept Platelets) and pathogen-reduced cryoprecipitated fibrinogen complex (Intercept Fibrinogen Complex) may improve blood availability for patients in need.
This program will take place at 2 p.m. ET on Wednesday, Nov. 30. Registration is complimentary but required to attend.
